We're excited to announce the launch of a brand new marijuana stock profile for Invictus MD Strategies Corp. (CSE:IMH) (OTC:IVITF) (FRA:8IS). Just this morning, Invictus MD announced a binding letter of intent to purchase a 100% stake in a late stage Canadian ACMPR applicant. This comes only a few weeks after Invictus MD announced their binding letter of intent to acquire 100% of PlanC BioPharm, another Licensed Producer applicant under Canada's ACMPR.
Shares of Invictus MD are responding positively to this morning's news, with OTC traded shares of Invictus MD (OTC:IVITF) up over 16% and CSE traded shares of Invictus MD (CSE:IMH) up approximately 16% as well.
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on acquiring licensed producers for cannabis cultivation in Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), and targets cannabis companies with proven brands, strong customer focus and significant growth potential in three verticals:
Cannabis cultivation in Canada
Cannabis fertilizer and nutrients
Date and delivery
For more information and recent news regarding Invictus MD Strategies Corp., be sure to check out the company's profile in our marijuana stocks database.
